[Action of actodigin (AY-22,241) in patients with cardiac insufficiency and chronic auricular fibrillation or flutter].
D000328:Adult; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001282:Atrial Flutter / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects*; D002297:Cardanolides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002301:Cardiac Glycosides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D004341:Drug Evaluation; D005260:Female; D005947:Glucose / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D012214:Rheumatic Heart Disease / Q000188:drug therapy
D002297:Cardanolides; D002301:Cardiac Glycosides; D005947:Glucose
Acción de la actodigina (AY-22,241) en pacientes con insuficiencia cardíaca y fibrilación o flutter auriculares chónicos